Ole Andreas Halvorsen
Viking Global Investors
Viking Global Investors 13F holdings
Ole Andreas Halvorsen's Portfolio
- Portfolio value:
- $26.09B≈
- # of securities:
- 63
- Reported for:
- 30 Sep 2015 (Q3)
- Latest filing date:
- 16 Nov 2015
What stocks did Ole Andreas Halvorsen own in 2015 Q3?
What was Ole Andreas Halvorsen's 2015 Q3 portfolio?
Viking Global Investors has disclosed a total of 63 security holdings in their (2015 Q3) SEC 13F filing(s) with portfolio value of $26,093,453,000.
Viking Global Investors's portfolio holdings are tracked quarterly based on SEC 13F filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
Ole Andreas Halvorsen's original 13F reports (2015 Q3) are the official SEC institutional disclosure documents covering all reported equity positions.
63 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
Security type |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
ACTAVIS INC COM STK (NV)
|
7.50%
|
$271.81
|
|
2013 Q2 or earlier
|
≈ 2.50+ years
|
Common Stock
|
+5.85% (+398.35K)
|
||||
|
|
Walgreens Boots Alliance Inc
|
7.41%
|
$83.10
|
|
2013 Q4
|
≈ 2.00 years
|
Common Stock
|
-5.49% (-1.35M)
|
||||
|
|
Alphabet Inc, CL-A
|
6.20%
|
$31.92
|
+923.14%($326.57)
|
2014 Q3
|
≈ 1.25 years
|
Common Stock
|
-7.38% (-4.04M)
|
||||
|
|
Amazon.com Inc
|
5.92%
|
$25.59
|
+805.98%($231.88)
|
2015 Q2
|
≈ 0.50 years
|
Common Stock
|
+32.21% (+14.7M)
|
||||
|
|
BROADCOM CORP, CL-A
|
4.65%
|
$51.43
|
|
2015 Q3
|
≈ 0.25 years
|
Common Stock
|
new
|
||||
|
|
LyondellBasell Industries NV
|
4.31%
|
$83.36
|
-29.16%($59.05)
|
2013 Q2 or earlier
|
≈ 2.50+ years
|
Common Stock
|
+25.91% (+2.78M)
|
||||
|
|
Valeant Pharmaceuticals International Inc
|
3.41%
|
$178.38
|
|
2013 Q2 or earlier
|
≈ 2.50+ years
|
Common Stock
|
+8.16% (+376.62K)
|
||||
|
|
Broadcom Inc
|
3.32%
|
$12.50
|
+2,940.40%($380.08)
|
2015 Q2
|
≈ 0.50 years
|
Common Stock
|
+45.51% (+21.7M)
|
||||
|
|
Elevance Health Inc
|
3.17%
|
$140.00
|
+170.06%($378.08)
|
2015 Q2
|
≈ 0.50 years
|
Common Stock
|
+210.15% (+4.01M)
|
||||
|
|
Pioneer Natural Resources Co
|
3.11%
|
$121.64
|
|
2014 Q1
|
≈ 1.75 years
|
Common Stock
|
+4.26% (+272.04K)
|
||||
Completely sold out
16 results
| History | Ticker | Name |
Sold shares* |
% change to portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|
|
|
MetLife Inc
|
2015 Q1
|
≈ 0.50 years
|
|||
|
|
CIGNA HOLDING CO
|
2015 Q2
|
≈ 0.25 years
|
|||
|
|
Fox Corp, CL-A
|
2015 Q2
|
≈ 0.25 years
|
|||
|
|
Baidu Inc
|
2013 Q3
|
≈ 2.00 years
|
|||
|
|
RECEPTOS INC
|
2014 Q4
|
≈ 0.75 years
|
|||
|
|
Biogen Inc
|
2015 Q2
|
≈ 0.25 years
|
|||
|
|
Aon PLC
|
2015 Q1
|
≈ 0.50 years
|
|||
|
|
Avis Budget Group Inc
|
2014 Q4
|
≈ 0.75 years
|
|||
|
|
Universal Health Services Inc
|
2015 Q2
|
≈ 0.25 years
|
|||
|
|
NXP SEMICONDUCTORS NV
|
2014 Q4
|
≈ 0.75 years
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.